©2015 Bloomberg News NSCTMP6K50Y3 (Bloomberg) — Merck & Co.’s vaccine for Ebola is “highly effective,” according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. The vaccine was 100 percent effective when it was tested on more than 4,000 people who were

published May 24th 2017, 5:18 pm, by Adam Haigh (Bloomberg) —Asian stocks were poised for a mixed start after the dollar declined with Treasury yields as investors assessed minutes from the Federal Reserve’s most recent meeting where officials said inflation remains muted. Fed policy makers said they needed to wait